1-7 of 7
Keywords: leukaemia
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem Soc Trans (2019) 47 (5): 1307–1325.
Published: 24 September 2019
...Caroline Busch; Helen Wheadon Chronic myeloid leukaemia (CML) is a paradigm of precision medicine, being one of the first cancers to be treated with targeted therapy. This has revolutionised CML therapy and patient outcome, with high survival rates. However, this now means an ever-increasing number...
Articles
Biochem Soc Trans (2015) 43 (5): 1089–1094.
Published: 09 October 2015
... (TRIB2) mammalian family member has been well characterized for its role in murine and human leukaemia, lung and liver cancer. One of the most characterized substrates for TRIB2-mediated degradation is the myeloid transcription factor CCAAT enhancer binding protein α (C/EBPα). However, across a number...
Articles
Biochem Soc Trans (2015) 43 (5): 1112–1115.
Published: 09 October 2015
..., Trib1, Trib2 and Trib3 are characterized by conserved motifs, including a pseudokinase domain and a C-terminal E3 ligase-binding domain. In this review, we focus on the role of Trib (mammalian Tribbles homologues) proteins in mammalian haematopoiesis and leukaemia. The Trib proteins show divergent...
Articles
Biochem Soc Trans (2014) 42 (6): 1556–1562.
Published: 17 November 2014
..., with complexity compounded by the finding that PKC isoforms can co-operate with or antagonize other PKC family members. A number of studies suggest the involvement of PKC family members in regulating leukaemic cell survival and proliferation. Chronic lymphocytic leukaemia (CLL), the most common leukaemia...
Articles
Biochem Soc Trans (2014) 42 (4): 809–815.
Published: 11 August 2014
...Parto Toofan; David Irvine; Lisa Hopcroft; Mhairi Copland; Helen Wheadon CML (chronic myeloid leukaemia) is characterized by the presence of the oncogenic tyrosine kinase fusion protein BCR (breakpoint cluster region)–Abl, responsible for driving the disease. Current TKI (tyrosine kinase inhibitor...
Articles
Biochem Soc Trans (2007) 35 (5): 1109–1113.
Published: 25 October 2007
.... 1 To whom correspondence should be addressed (email dfruman@uci.edu ). 10 6 2007 © The Authors Journal compilation © 2007 Biochemical Society 2007 chemokine chemotaxis leukaemia lymphocyte phosphoinositide 3-kinase (PI3K) two-photon microscopy Lymphocytes (T- and B...
Articles
Biochem Soc Trans (2004) 32 (2): 315–319.
Published: 01 April 2004
... cells, and certain oncogenes cause leukaemia in part by promoting PI3K signalling. Genetic manipulation of this pathway, together with biochemical studies in primary lymphocytes, has begun to shed light on the molecular mechanisms by which PI3K contributes to the proliferation of normal and transformed...